NASA Artemis Astronaut Picks Signal $2.6B SpaceX, Blue Origin Contract Milestone
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
NASA announced the selection of U.S. and Italian astronauts for its Artemis II moon mission on June 9, 2026, formally activating the next phase of its $2.6 billion contracts with SpaceX and Blue Origin. The crew assignment confirms the 2029 launch target for the first human lunar landing since 1972, utilizing the SpaceX Starship and Blue Origin Blue Moon landers. This procedural milestone releases the next tranche of contract funding to the private contractors.
The Artemis program represents the first major human spaceflight procurement cycle since the Space Shuttle era, shifting NASA's role to a primary customer rather than a builder. Congress appropriated $7.5 billion for the Human Landing System (HLS) program in fiscal year 2026, a 12% increase over the previous year's budget. The astronaut selection accelerates the contractual timeline, moving funds from obligated to expended status and triggering supplier payments.
This development occurs amid heightened geopolitical competition in space, with China's lunar program targeting a 2030 crewed landing. The U.S. strategic objective is to establish a sustained presence through the Artemis Accords, which now have 38 signatory nations. The crew announcement forces the issue of budgetary certainty for a program that has faced congressional scrutiny over cost overruns.
The combined value of NASA's fixed-price contracts with SpaceX and Blue Origin is $2.6 billion for the initial demonstration missions. SpaceX's contract is valued at approximately $1.9 billion, while Blue Origin's is valued at $700 million for its Blue Moon lander. NASA's total Artemis program budget request for FY2027 is $8.1 billion, part of a $93 billion projected total cost through 2030.
The defense and aerospace sector ETF, ITA, has gained 14% year-to-date, outperforming the SPX's 8% gain. Prime contractors like Northrop Grumman (NOC) and Lockheed Martin (LMT) derive an estimated 18-22% of revenue from NASA and space-related contracts. The astronaut selection initiates a 36-month pre-launch operational timeline, with major hardware delivery milestones clustered in 2027.
| Metric | Value |
|---|---|
| Total HLS Contract Value | $2.6B |
| SpaceX Share | $1.9B |
| Blue Origin Share | $0.7B |
| ITA ETF YTD Performance | +14% |
The immediate beneficiaries are the direct contractors, SpaceX (privately held) and Blue Origin, alongside public subcontractors. Aerojet Rocketdyne (AJRD) supplies propulsion systems for both landers, with an estimated 15% revenue exposure to Artemis. Lockheed Martin (LMT) is the prime contractor for the Orion crew capsule, with its space segment revenue comprising 29% of total sales.
Second-order effects flow to materials and specialized components. Steel producer STLD benefits from increased demand for specialty alloys used in launch infrastructure. Semiconductor firms like LRCX and AMAT see increased orders for fabrication equipment used in radiation-hardened chips. A key risk is congressional budget instability, as the program requires annual appropriations that could be disrupted by political shifts.
Institutional flow data shows increased options volume on defense ETFs like ITA and PPA, with call buying outpacing puts 3-to-1 last week. Long-only funds are increasing weightings in mid-cap aerospace suppliers like BWXT and MAXR, anticipating a multi-year capex cycle.
The next major catalyst is the Artemis II Orion capsule stress test results, scheduled for release on August 15, 2026. This will be followed by the SpaceX Starship uncrewed lunar orbital test, currently slated for Q1 2027. Congressional FY2027 appropriations debates in September will provide clarity on continued funding levels.
Market participants should monitor the ITA ETF for a sustained breakout above its 200-day moving average at $125.50. Any failure to hold the $120 support level would signal skepticism about contract execution. Key earnings calls for LMT and NOC in late July will provide management guidance on Artemis-related revenue recognition timelines.
Retail investors gain exposure primarily through publicly traded contractors and suppliers, not the private companies leading the effort. ETFs like ITA (iShares U.S. Aerospace & ETF) and PPA (Invesco Aerospace & Defense ETF) offer diversified baskets of stocks with high NASA and government exposure. These ETFs have outperformed the broader market, but carry concentration risk in government budgeting cycles.
SpaceX holds a larger, single-award contract valued at $1.9 billion to develop and demonstrate the Starship human landing system. Blue Origin leads a national team including Lockheed Martin and Draper for its $700 million contract, focusing on a more traditional lander design. The dual-source strategy ensures competition and redundancy but may create a long-term primary supplier.
The Apollo program cost approximately $260 billion in today's dollars, concentrated over a decade. Artemis has a projected cost of $93 billion through 2030, representing a more sustained but less intense expenditure profile. The key difference is the reliance on public-private partnerships, transferring more development risk and initial capital expenditure to private entities like SpaceX.
NASA's crew assignment confirms the Artemis program's operational timeline and releases critical funding to its private contractors.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.